Disclosed herein are substituted pyrrolidine-based muscarinic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
METHOD FOR PREPARING 1,3-DISUBSTITUTED PYRROLIDINE COMPOUNDS
申请人:Soldevilla Madrid Núria
公开号:US20090306406A1
公开(公告)日:2009-12-10
A process for preparing substituted pyrrolidine compounds, including (5)-2-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide, commonly known in the art as darifenacin, comprising reacting a pyrrolidine compound with a benzofuran derivative in the presence of a phase-transfer catalyst.
[EN] PURE DARIFENACIN HYDROBROMIDE SUBSTANTIALLY FREE OF OXIDIZED DARIFENACIN AND SALTS THEREOF AND PROCESSES FOR THE PREPARATION THEREOF<br/>[FR] BROMHYDRATE DE DARIFENACINE PUR SENSIBLEMENT EXEMPT DE DARIFENACINE OXYDEE, SELS DE CELUI-CI, ET PROCEDES DE PREPARATION DE CEUX-CI
申请人:TEVA PHARM FINE CHEMICALS SRL
公开号:WO2007076159A2
公开(公告)日:2007-07-05
[EN] Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof. [FR] L'invention concerne du bromhydrate de darifénacine exempt de darifénacine oxydée, et des procédés de préparation de celui-ci.